The pathophysiology of thrombocytopenia in chronic liver disease
Oscar Mitchell,1 David M Feldman,1,2 Marla Diakow,1 Samuel H Sigal3 1Department of Medicine, 2Division of Gastroenterology and Liver Diseases, New York University School of Medicine, Langone Medical Center, New York, 3Division of Gastroenterology and Liver Diseases, Department of Medicine, Montefior...
Guardado en:
Autores principales: | Mitchell O, Feldman DM, Diakow M, Sigal SH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eba3a73a6086437185bac69f066aa6f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Implications of Thrombocytopenia for the Cirrhotic Patient
por: Sigal SH, et al.
Publicado: (2020) -
Autonomic dysfunction in chronic liver disease
por: Frith J, et al.
Publicado: (2011) -
A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
por: Ganguli S, et al.
Publicado: (2019) -
Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study
por: Tracey G. Simon, et al.
Publicado: (2021) -
The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
por: Danish FA, et al.
Publicado: (2013)